Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 15, 2022

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2024

Conditions
Type 2 Diabetes Mellitus
Interventions
OTHER

GA guided anti-diabetic therapy adjustment

The GA concentration will be measured at 4-week intervals in both groups. The anti-diabetic treatment regimen will be strengthened when GA value is higher than 16% at 4 weeks.

OTHER

current guidelines to adjust treatment

The GA concentration will be measured at 4-week intervals. Investigators will be not aware of the GA value and rely on the current guidelines to adjust treatment.

Trial Locations (7)

Unknown

The third people's hospital of DATONG, Datong

Beijing Haidian Hospital, Beijing

Beijing Pinggu District Hospital, Beijing

Beijing Shijingshan Hospital, Beijing

Beijing Tiantan Hospital, Capital Medical University, Beijing

Civil Aviation General Hospital, Beijing

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Asahi Kasei Pharma Corporation

INDUSTRY